PFIZER REPORTS THIRD-QUARTER 2018 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Pfizer (PFE) PT Raised to $42 at Credit Suisse
October 31, 2018 8:56 AM EDTCredit Suisse analyst Vamil Divan raised the price target on Pfizer (NYSE: PFE) to $42.00 (from $40.00) while maintaining a Neutral rating.
... MorePfizer (PFE) Tops Q3 EPS by 3c
October 30, 2018 6:47 AM EDTPfizer (NYSE: PFE) reported Q3 EPS of $0.78, $0.03 better than the analyst estimate of $0.75. Revenue for the quarter came in at $13.3 billion versus the consensus estimate of $13.53 billion.
GUIDANCE:
Pfizer sees FY2018 EPS of $2.98-$3.02, versus the consensus of $2.99.Now... More